The Billion-Dollar AI Drug Discovery Deal Wave: Pharma R&D Structural Transformation
The first half of 2026 witnessed an unprecedented wave of billion-dollar deals in AI drug discovery. Eli Lilly and NVIDIA jointly announced a $1 billi...
Medical Technology
World's First AI-Designed Universal Coronavirus Vaccine Passes Human Trial: A Paradigm Shift from Reactive to Predictive Vaccine Development
In June 2026, researchers from the University of Cambridge and its spinout DIOSynVax (DVX) published results in the Journal of Infection from the firs...
Cartilage Regeneration Breakthrough: Stanford Single Injection Reverses Osteoarthritis
On June 12, 2026, a Stanford University research team published a landmark study in the journal Science that could fundamentally transform the treatme...
CRISPR Gene Editing 2026: The Clinical Turning Point from Ex Vivo Casgevy to Direct In Vivo Delivery
In December 2023, Casgevy (exa-cel) received FDA and UK MHRA approval, becoming the world first approved CRISPR gene-editing therapy. It proved CRISPR...
Organoid Intelligence: When Lab-Grown Human Brain Tissue Becomes the Next Computing Platform
In a Lausanne laboratory, sixteen pinhead-sized blobs of living human brain tissue float inside microfluidic chambers, bathed in nutrients, threaded w...
AI-Designed Drugs Enter Human Trials: How Isomorphic Labs Pushes AlphaFold From Prediction to Creation
In 2026, a cancer treatment drug designed entirely by AI from scratch is entering Phase 1 clinical trials. This is not a story about an assistive scre...
AI Drug Discovery 2026: 173 Clinical Programs and the Inflection Point of Commercialization
2026 marks the critical inflection point for AI-driven drug discovery — transitioning from proof of concept to industrialization. As of mid-2026, over...
AI vs Antimicrobial Resistance: The Computational Revolution in Antibiotic Discovery
In 2019, before the COVID-19 pandemic reshaped global health priorities, antimicrobial resistance (AMR) was already ranked among the top ten global pu...
CAR-T's Next Frontier: Autoimmune Diseases — A Paradigm Shift from Cancer Treatment to Lupus and Multiple Sclerosis
CAR-T cell therapy — a treatment that has achieved revolutionary success in oncology — is expanding its front from cancer to autoimmune diseases. In J...
Three Breakthrough Pathways: Glioblastoma Treatment in 2026 Embraces Targeted, Nanomedicine, and Immune Strategies
Glioblastoma Multiforme (GBM) is the most common and most lethal primary malignant brain tumour in adults, with a median survival of only 12-15 months...
The Non-Invasive Deep Brain Stimulation Revolution: How Temporal Interference and Focused Ultrasound are Rewriting Neurological Treatment
Traditional Deep Brain Stimulation (DBS) surgery requires drilling holes in the patient's skull, precisely implanting electrodes into specific nuclei ...
China's NEO Brain Implant Goes Commercial: How the World's First Approved Invasive BCI is Reshaping Neurotechnology
In June 2026, China's National Medical Products Administration (NMPA) formally approved the NEO Brain-Computer Interface (BCI) chip, jointly developed...
AI Surgical Navigation: Color-Coding Human Tissue in the Age of Precision Surgery
In May 2026, the UK's National Health Service (NHS) performed its first clinical surgery using a technology called "AI Color Vision Navigation." At a ...
From Diabetes Tool to Consumer Wearable
From Diabetes Tool to Consumer Wearable
For decades, blood glucose monitoring meant finger pricks — a painful, inconvenient, and intermittent ritual t...
Apple Watch AFib Detection Study: 200,000 Participants, 97% Accuracy
Apple Watch AFib Detection Study: 200,000 Participants, 97% Accuracy
A landmark study involving over 200,000 participants has validated the Apple Watc...
Moderna mRNA Cancer Vaccine Phase 3: 65% Melanoma Recurrence Reduction
Moderna Therapeutics has announced the first Phase 3 clinical trial results for its personalized mRNA cancer vaccine, revealing a 65 percent reduction...
A Milestone for CRISPR Medicine
A Milestone for CRISPR Medicine
The U.S. Food and Drug Administration has expanded the approval of Casgevy (exagamglogene autotemcel), the world's fir...
Base Editing Technology Cures Sickle Cell Disease for the First Time: Human Validation of Precision Gene Correction
Base Editing Technology Cures Sickle Cell Disease for the First Time: Human Validation of Precision Gene Correction
First patient receiving base editi...
CAR-T Cell Therapy Conquers Solid Tumors: Novel Targeting Strategies Achieve Breakthroughs
CAR-T Cell Therapy Conquers Solid Tumors: Novel Targeting Strategies Achieve Breakthroughs
Claudin18.2 CAR-T achieves 45% objective response rate in g...
AI Radiology Diagnostic Systems Surpass Human Physicians: FDA Approves Autonomous Interpretation Platform
AI Radiology Diagnostic Systems Surpass Human Physicians: FDA Approves Autonomous Interpretation Platform
Deep learning models exceed radiologist accu...
Anti-Aging Drugs Enter Human Trials: Aging Intervention Research Fully Underway
Anti-Aging Drugs Enter Human Trials: Aging Intervention Research Fully Underway
Senolytics, mTOR inhibitors, and NAD+ enhancers show clinical trial re...
Nanoparticle Drug Delivery Systems: Next-Generation Loading Technology for Precise Tumor Targeting
Nanoparticle Drug Delivery Systems: Next-Generation Loading Technology for Precise Tumor Targeting
Lipid nanoparticles and DNA origami technology enab...
Gut Microbiome Therapy Approved: Fecal Microbiota Transplantation Enters the Precision Medicine Era
Gut Microbiome Therapy Approved: Fecal Microbiota Transplantation Enters the Precision Medicine Era
First standardized microbiome therapy receives FDA...
Liquid Biopsy Goes Mainstream: The Era of Detecting 50 Cancers from a Drop of Blood
Liquid Biopsy Goes Mainstream: The Era of Detecting 50 Cancers from a Drop of Blood
Next-generation methylation-based liquid biopsy technology pushes ...
A New Era in Alzheimer's Treatment: Anti-Amyloid Combination Therapy Doubles Effects
A New Era in Alzheimer's Treatment: Anti-Amyloid Combination Therapy Doubles Effects
Lecanemab receives full FDA approval, Donanemab Phase 3 succeeds,...
ALS Gene Therapy Receives FDA Breakthrough Designation: Antisense Oligonucleotide Drugs Alter Disease Course
ALS Gene Therapy Receives FDA Breakthrough Designation: Antisense Oligonucleotide Drugs Alter Disease Course
Biogen's Qalsody (tofersen) reduces neuro...
mRNA Cancer Vaccine Clinical Breakthrough: Personalized Therapy Enters Phase 3 Trials
mRNA Cancer Vaccine Clinical Breakthrough: Personalized Therapy Enters Phase 3 Trials
Moderna/Merck's mRNA-4157 (V940) combined with Keytruda reduces ...
The Evolution of Surgical Robots: From da Vinci's Monopoly to the New AI-Empowered Era
The Evolution of Surgical Robots: From da Vinci's Monopoly to the New AI-Empowered Era
The global surgical robot market has long been dominated by Int...
Prime Editing Enters Human Clinical Trials: The Precision Revolution in Gene Editing
Prime Editing Enters Human Clinical Trials: The Precision Revolution in Gene Editing
If CRISPR-Cas9 is the "scissors" of gene editing, then Prime Edit...
Moderna's mRNA Flu Vaccine Phase III Victory: Platform Technology Validation
Moderna's mRNA Flu Vaccine Phase III Victory: Platform Technology Validation
In mid-2024, Moderna announced that its trivalent mRNA influenza vaccine ...
CRISPR Gene Editing Therapy Casgevy: From Proof of Concept to Clinical Success
CRISPR Gene Editing Therapy Casgevy: From Proof of Concept to Clinical Success
In November 2023, the UK Medicines and Healthcare products Regulatory A...